Assessing epidermal growth factor receptor expression in tumours: What is the value of current test methods?

This publication has 47 references indexed in Scilit:

• Impact of EGFR expression on colorectal cancer patient prognosis and survival
  Annals of Oncology, 2005
• Prognostic significance of EGF receptor expression in early glottic cancer
  Auris Nasus Larynx, 2004
• EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib
  Proceedings of the National Academy of Sciences, 2004
• Determinants of Tumor Response and Survival With Erlotinib in Patients With Non—Small-Cell Lung Cancer
  Journal of Clinical Oncology, 2004
• EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
  Science, 2004
• Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib
  New England Journal of Medicine, 2004
• Pharmacodiagnostic Value of the HER Family in Head and Neck Squamous Cell Carcinoma
  ORL, 2004
• EGFR and cancer prognosis
  Published by Elsevier ,2001
• The EGFR as a target for anticancer therapy—focus on cetuximab
  European Journal Of Cancer, 2001
• Distribution and number of epidermal growth factor receptors in skin is related to epithelial cell growth
  Developmental Biology, 1983